What is cefoperazone injection used for?
Pharmaceutical Product Monograph: Cefoperazone Sodium Injection (500 mg, 1 g)
In the pharmaceutical industry, Cefoperazone is a semi-synthetic, broad-spectrum Third-Generation Cephalosporin antibiotic. As a pharmacist and manufacturer at your WHO-GMP facility in Mumbai, I view this molecule as a “Biliary Specialist”—it is technically unique among cephalosporins because it is primarily excreted through the bile rather than the kidneys, making it a critical tool for patients with renal impairment.
Cefoperazone is a potent $\beta$-lactam antibiotic specifically designed to target difficult-to-treat Gram-negative bacteria, including Pseudomonas aeruginosa.
Therapeutic Profile: Primary Indications
Cefoperazone injection is indicated for the treatment of severe infections caused by susceptible microorganisms, particularly in the respiratory and abdominal tracts.
| Indication | Clinical Context | Technical Rationale |
| Biliary Tract Infections | Cholecystitis / Cholangitis | Drug of Choice. Achieves high therapeutic concentrations in the bile and gallbladder. |
| Respiratory Infections | Severe Pneumonia | Effective against a wide range of pathogens, including those resistant to earlier penicillins. |
| Peritonitis | Intra-abdominal Sepsis | Often used in combination with Sulbactam to cover anaerobic bacteria and resistant strains. |
| Septicemia | Bloodstream Infection | Used as an empirical intravenous treatment for suspected bacterial sepsis. |
| Skin & Soft Tissue | Diabetic Foot / Ulcers | Targets Pseudomonas and other Gram-negative bacilli in deep tissue infections. |
Mechanism: Inhibition of Bacterial Cell Wall Synthesis
Cefoperazone works by disrupting the structural integrity of the bacterial cell wall during the active growth phase:
PBP Binding: The molecule binds to specific Penicillin-Binding Proteins (PBPs) located on the inner membrane of the bacterial cell.
Peptidoglycan Blockade: It inhibits the final “transpeptidation” step of cell wall synthesis, preventing the cross-linking of peptidoglycan strands.
Osmotic Lysis: The weakened cell wall cannot withstand internal pressure. Water enters the cell, causing it to swell and burst (Lysis), resulting in bacterial death.
The Pharmacist’s “Technical Warning”
The “Disulfiram” Reaction: As a pharmacist, I must warn: Patients must avoid alcohol during and for 72 hours after treatment. Cefoperazone contains a N-methylthiotetrazole (MTT) side chain that can cause severe nausea, vomiting, and tachycardia if alcohol is consumed.
Hypoprothrombinemia: The MTT side chain can also interfere with Vitamin K metabolism, potentially leading to increased bleeding. Patients on anticoagulants (like Warfarin) require close monitoring.
Biliary Sludging: Due to high biliary excretion, rare cases of “pseudolithiasis” (gallbladder sludging) can occur, which usually resolves after stopping the drug.
Renal Safety: Unlike Ceftriaxone or Ceftazidime, Cefoperazone does not technically require dose adjustment in patients with Renal Failure, making it safer for geriatric or dialysis patients.
The Manufacturer’s Perspective: Technical & Export
From a production and B2B standpoint at your facility in Mumbai:
The “Sulbactam Synergy” USP: On your digital marketplace, highlight your Cefoperazone + Sulbactam (1:1 or 2:1) combinations. Sulbactam protects Cefoperazone from $\beta$-lactamase enzymes, making the combination a market leader in ICU and critical care settings.
Stability for Export: Cefoperazone Sodium is light-sensitive. Your Amber USP Type I glass vials and nitrogen-blanketed filling process ensure a 24-month shelf life in the heat of Zone IVb climates.
Dossier Support: We provide full WHO-standard CTD/eCTD Dossiers for Cefoperazone 1g and combination vials to support your registration in international B2B tenders for hospital and surgical supplies.